Your browser doesn't support javascript.
loading
Kohlschütter-Tönz Syndrome With a Novel ROGD1 Variant in 3 Individuals: A Rare Clinical Entity.
Akgün-Dogan, Özlem; Simsek-Kiper, Pelin Ozlem; Taskiran, Ekim; Schossig, Anna; Utine, Gülen Eda; Zschocke, Johannes; Boduroglu, Koray.
Afiliação
  • Akgün-Dogan Ö; Division of Pediatric Genetics, Department of Pediatrics, 37515Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Simsek-Kiper PO; Division of Pediatric Genetics, Department of Pediatrics, 37515Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Taskiran E; Department of Medical Genetics, 64005Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Schossig A; Institute of Human Genetics, 27280Medical University Innsbruck, Innsbruck, Austria.
  • Utine GE; Division of Pediatric Genetics, Department of Pediatrics, 37515Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Zschocke J; Institute of Human Genetics, 27280Medical University Innsbruck, Innsbruck, Austria.
  • Boduroglu K; Division of Pediatric Genetics, Department of Pediatrics, 37515Hacettepe University Faculty of Medicine, Ankara, Turkey.
J Child Neurol ; 36(10): 816-822, 2021 09.
Article em En | MEDLINE | ID: mdl-33866847
Kohlschütter-Tönz syndrome (OMIM 226750) is a rare disorder with autosomal recessive inheritance among epileptic encephalopathy syndromes. To date, only 31 Kohlschütter-Tönz syndrome families have been reported in the literature. Early-onset epilepsy, progressive global developmental delay, and amelogenesis imperfecta are the main components of the syndrome. Mutations in ROGDI (MIM 226750) and SLC13A5 (MIM 615905) are responsible for Kohlschütter-Tönz syndrome. Here, we report on the clinical and molecular characteristics of 3 individuals from 2 families, all harboring the same homozygous novel deleterious variant in ROGD1, along with a long-term follow-up and review of the literature. Although the phenotypic features are almost consistent in Kohlschütter-Tönz syndrome, overlooking dental findings and diverse degrees of variability in clinical findings makes diagnosis challenging occasionally. Because there is a limited number of reported patients, identification of new patients and delineation of clinical and molecular findings will increase the awareness of clinicians and enable establishing genotype-phenotype correlations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Demência / Epilepsia / Amelogênese Imperfeita / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Demência / Epilepsia / Amelogênese Imperfeita / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article